Cargando…

Effects of focal/grid laser treatment on the central visual field in diabetic macular oedema: a 2‐year follow‐up study

PURPOSE: To assess the long‐term effects of focal/grid laser treatment on the central visual field in subjects with clinically significant diabetic macular oedema (CSMO). METHODS: Twenty‐six subjects with CSMO were included in the study. Fundus photography, assessment of retinal thickness by time‐do...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tababat‐Khani, Poya, Bengtsson, Boel, Agardh, Elisabet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066669/ https://www.ncbi.nlm.nih.gov/pubmed/26806322 http://dx.doi.org/10.1111/aos.12956

Ejemplares similares

Adopting 3-Year Screening Intervals for Sight-Threatening Retinal Vascular Lesions in Type 2 Diabetic Subjects Without Retinopathy
por: Agardh, Elisabet, et al.
Publicado: (2011)

Photocoagulation of Human Retinal Pigment Epithelial Cells In Vitro: Evaluation of Necrosis, Apoptosis, Cell Migration, Cell Proliferation and Expression of Tissue Repairing and Cytoprotective Genes
por: Tababat-Khani, Poya, et al.
Publicado: (2013)

Randomised clinical trial evaluating best-corrected visual acuity and central macular thickness after 532-nm subthreshold laser grid photocoagulation treatment in diabetic macular oedema
por: Pei-pei, W, et al.
Publicado: (2015)

Indicators of Visual Prognosis in Diabetic Macular Oedema
por: Sen, Sagnik, et al.
Publicado: (2021)

Rates of visual field progression in clinical glaucoma care
por: Heijl, Anders, et al.
Publicado: (2012)

Treatments for macular oedema following central retinal vein occlusion: systematic review
por: Ford, John A, et al.
Publicado: (2014)

Lack of Visual Field Improvement After Initiation of Intraocular Pressure Reducing Treatment in the Early Manifest Glaucoma Trial
por: Bengtsson, Boel, et al.
Publicado: (2016)

Impact of metabolic control on macular thickness in diabetic macular oedema
por: Peng, Yi-Jie, et al.
Publicado: (2017)

Association of OCT biomarkers and visual impairment in patients with diabetic macular oedema with vitreomacular adhesion
por: Subramanian, Brughanya, et al.
Publicado: (2023)

Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab
por: Talks, S. James, et al.
Publicado: (2019)

Optical coherence tomography imaging of macular oedema
por: Trichonas, George, et al.
Publicado: (2014)

Remote examination of exudates-impact of macular oedema
por: Punniyamoorthy, Uma, et al.
Publicado: (2018)

Diabetic Macular Oedema Guidelines: An Australian Perspective
por: Yuen, Yew Sen, et al.
Publicado: (2023)

Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up
por: Romero-Aroca, Pedro, et al.
Publicado: (2016)

Subthreshold micropulse laser versus standard laser for the treatment of central-involving diabetic macular oedema with central retinal thickness of <400µ: a cost-effectiveness analysis from the DIAMONDS trial
por: Mistry, Hema, et al.
Publicado: (2023)

Clinically meaningful visual improvements and predictors of early vision gains with ranibizumab for diabetic macular oedema
por: Morse, Lawrence, et al.
Publicado: (2019)

Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I data
por: Sadda, Srinivas R., et al.
Publicado: (2019)

Evaluation of effect of bevacizumab on central subfield macular thickness in the injected and contralateral (untreated) eye of patients with bilateral diabetic macular oedema
por: Khatri, Anadi, et al.
Publicado: (2017)

Should we still be performing macular laser for non-centre involving diabetic macular oedema? Results from a UK centre
por: Scanlon, Peter H., et al.
Publicado: (2021)

Perifoveal Microcirculation in Macular Oedema with Retinal Vein Occlusion
por: Noma, Hidetaka, et al.
Publicado: (2012)

Transient Cystoid Macular Oedema in Multiple Choroidal Naevi
por: Ziahosseini, Kimia, et al.
Publicado: (2013)

Inflammation and Macular Oedema after Pars Plana Vitrectomy
por: Romano, Vito, et al.
Publicado: (2013)

Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
por: Shibeeb, O'Sam, et al.
Publicado: (2014)

Evaluation of intravitreal bevacizumab as monotherapy and in combination with macular grid laser photocoagulation in diffuse diabetic macular edema
por: Das, Gopal K., et al.
Publicado: (2018)

Impact on visual acuity and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY)
por: Sakamoto, Taiji, et al.
Publicado: (2021)

Two-year visual and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY)
por: Sakamoto, Taiji, et al.
Publicado: (2022)

Drug treatment of macular oedema secondary to central retinal vein occlusion: a network meta-analysis
por: Ford, John A, et al.
Publicado: (2014)

Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial
por: Lois, Noemi, et al.
Publicado: (2019)

Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO)
por: Cornish, E. E., et al.
Publicado: (2023)

Functional and structural efficacy of a novel combinational therapy of aflibercept and timely focal/grid photocoagulation in diabetic macular oedema: do clinical study results compare favourably with a standard‐of‐care treated real‐world population?
por: Jørgensen, Mathias M., et al.
Publicado: (2022)

Comparative Evaluation Between Ranibizumab Combined with Laser and Bevacizumab Combined with Laser Versus Laser Alone for Macular Oedema Secondary to Branch Retinal Vein Occlusion
por: Azad, Shorya Vardhan, et al.
Publicado: (2014)

Visual impairment and vision‐related quality of life in the Early Manifest Glaucoma Trial after 20 years of follow‐up
por: Peters, Dorothea, et al.
Publicado: (2015)

Cystoid macular oedema in Cogans syndrome-a case report
por: Pherwani, Anupama, et al.
Publicado: (2008)

Acetazolamide for Cystoid Macular Oedema in Bietti Crystalline Retinal Dystrophy
por: Broadhead, Geoffrey K, et al.
Publicado: (2014)

Aflibercept versus ranibizumab for treating persistent diabetic macular oedema
por: ROA Vandekerckhove, Kristof
Publicado: (2015)

Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema
por: Mateos-Olivares, Milagros, et al.
Publicado: (2021)

Chronic Macular Oedema as a Late MIRAgel-Related Complication
por: Chean, Chung Shen, et al.
Publicado: (2021)

Visual acuity time in range: a novel concept to describe consistency in treatment response in diabetic macular oedema
por: Kozak, Igor, et al.
Publicado: (2023)

The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema
por: Lang, Gabriele E., et al.
Publicado: (2017)

Focal Laser Photocoagulation in Non-Center Involved Diabetic Macular Edema
por: Perente, Irfan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8jvgq1mghj6kc63to65udj2m9a